Olmesartan Medoxomil (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Olmesartan Medoxomil drug offered from Mylan Institutional Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
NON-PROPRIETARY NAME: | olmesartan medoxomil |
SUBSTANCE NAME: | OLMESARTAN MEDOXOMIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-11-10 |
END MARKETING DATE: | 0000-00-00 |
Olmesartan Medoxomil HUMAN PRESCRIPTION DRUG Details:
Item Description | Olmesartan Medoxomil from Mylan Institutional Inc. |
LABELER NAME: | Mylan Institutional Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2016-11-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42292-036_40f98014-b182-2b0f-e054-00144ff8d46c |
PRODUCT NDC: | 42292-036 |
APPLICATION NUMBER: | ANDA078276 |
Other OLMESARTAN MEDOXOMIL Pharmaceutical Manufacturers / Labelers: